
A new study published in The Ocular Surface, has shed light on the quality-of-life impact of dry eye disease (DED) with authors, including optometrists and ophthalmologists from the UK and Australia, noting a need for individualised treatment strategies.
Using Rasch analysis, individuals with mixed subtype DED, corneal neuropathic pain, a history of DED treatment, or past DED-related procedures were found to have worse symptoms, activity limitations and quality of life than those with evaporative or aqueous-deficient DED.
‘Our results highlight that DED is more than just a clinical condition – it significantly affects mental health, daily activities, and overall well-being,’ said lead author Himal Kandel from the University of Sydney.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here